Die Literaturstellen können bei Herrn Priv.-Doz. Dr. Schmermund unter A.Schmermund(at)ccb.de angefordert werden.

1. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary eventsbased on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) Study. Circulation 2002;105:310-315
2. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehab 2003;10 (Suppl 1):S1-S78
3. Löwel H, Meisinger C, Heier M et al. Geschlechtsspezifische Trends von plötzlichem Herztod und akutem Herzinfarkt. Dtsch Med Wochenschr 2002;127:2311-2316
4. Nissen SE, Tuzcu EM, Schoenhagen P, et al. REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080
5. Schmermund A, Erbel R. Neue Konzepte der Primärprävention erfordern Umdenken. Med Klin 2001;96:261-269
6. Schmermund A, Erbel R. Current Perspective: Unstable coronary plaque and its relation to coronary calcium. Circulation 2001;104:1682-1687
7. Schmermund A, Erbel R. Therapie der Arteriosklerose. Dtsch Med Wochenschr 2003;128:41-47
8. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. Circulation 2002;106:3143-3421
9. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular disease. Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-2864